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Letter to the Editor
Response to Ravnskov et al. on saturated fat and CHD
(First published online 13 December 2011)
We thank Dr Ravnskov and colleagues(1) for their interest
in our editorial. Ravnskov et al. appear to ignore the large
number of controlled metabolic studies relating fatty acid
intake to plasma total and LDL-cholesterol as well as the
overwhelming evidence that LDL is causally related to the
atherosclerotic process.
The issues that Ravnskov et al. raise were raised earlier
in sixty-two Letters to the Editor, which Dr Ravnskov has
published about lipids and heart disease in the past 20
years(2–63). His letters have appeared in JAMA, the New
England Journal of Medicine, the British Medical Journal,
the Lancet, Science, the American Journal of Clinical
Nutrition, Annals of Internal Medicine, the Journal of Clinical
Epidemiology, the International Journal of Cardiology, Circu-
lation, the Quarterly Journal of Medicine, the Journal of the
National Cancer Institute, Nutrition Metabolism and Cardio-
vascular diseases, several Scandinavian medical journals, and
now in the British Journal of Nutrition.
All these letters argue essentially the same point, namely
that lowering blood cholesterol levels is of unproven value.
We refer readers to the responses of dozens of reputable
scientists set out in each journal’s Letters section, where they
have carefully responded to Dr Ravnskov’s letters and
shown that, by and large, Ravnskov’s arguments are faulty.
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